Found 6 matching trials
Pharmacokinetic, Safety, Tolerability and Immunogenicity Study of SB3 in Healthy Male Subjects PHASE1 The purpose of this study is to compare the pharmacokinetics, safety, toler...
Show More Location
Samsung Investigational Site
Learn More & Join Trial
Compare Efficacy, Safety and Immunogenicity of HLX02 and Herceptin in Previously Untreated HER2 +Overexpressing Metastatic Breast Cancer PHASE3 This is a Phase III, double-blind, randomized multicenter study to compare ...
Show More Location
The First Affiliated Hospital of Anhui Medical University
Learn More & Join Trial
A Pharmacokinetic Study Comparing PF-05280014 And Trastuzumab In Healthy Male Volunteers (REFLECTIONS B327-01) PHASE1 In this study, healthy male volunteers will receive a single intravenous ad...
Show More Location
Pfizer Investigational Site
Learn More & Join Trial
Efficacy and Safety Study of EG1206A (EirGenix' Pertuzumab) Compared With EU-sourced Perjeta® (Pertuzumab) in Patients With HER2-positive Hormone Receptor Negative Early Breast Cancer. PHASE3 The purpose of this research study is to compare the efficacy and safety of...
Show More Location
Methodist Health System Clinical Research Institute
Learn More & Join Trial
A Pharmacokinetic Study Comparing EG12014 and Herceptin (Trastuzumab) in Healthy Male Volunteers PHASE1 The primary objective of this trial is to assess the pharmacokinetic simila...
Show More Location
Multiple Locations
Learn More & Join Trial
A Safety and Pharmacokinetic Study Between HLX02 and Herceptin®(US-licensed and EU-approved) in Healthy Chinese Male Subjects PHASE1 Randomised, double-blind, parallel group Phase I study to compare PK profil...
Show More Location
The Second Affiliated Hospital of Soochow University
Learn More & Join Trial